Addex Therapeutics Ltd
SIX:ADXN
Addex Therapeutics Ltd
Depreciation & Amortization
Addex Therapeutics Ltd
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Addex Therapeutics Ltd
SIX:ADXN
|
Depreciation & Amortization
-CHf25.4k
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Idorsia Ltd
SIX:IDIA
|
Depreciation & Amortization
-CHf21.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-189%
|
CAGR 10-Years
N/A
|
See Also
What is Addex Therapeutics Ltd's Depreciation & Amortization?
Depreciation & Amortization
-25.4k
CHF
Based on the financial report for Dec 31, 2023, Addex Therapeutics Ltd's Depreciation & Amortization amounts to -25.4k CHF.
What is Addex Therapeutics Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-54%
Over the last year, the Depreciation & Amortization growth was 20%. The average annual Depreciation & Amortization growth rates for Addex Therapeutics Ltd have been -10% over the past three years , -54% over the past five years .